BRITTANY WALSH: Open Payments
NPI 1528596715 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,060 in 102 payments from 18 companies in 2025. Trend: 2023 $1,830 · 2024 $1,770 · 2025 $2,060
Food & beverage: $1,963Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $401 |
| Novartis Pharmaceuticals Corporation | 12 | $210 |
| Galderma Laboratories, L.P. | 11 | $206 |
| Botanix SB Inc | 5 | $175 |
| GENZYME CORPORATION | 5 | $159 |
| Arcutis Biotherapeutics, Inc. | 6 | $152 |
| UCB, Inc. | 9 | $147 |
| LEO Pharma Inc. | 5 | $106 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Amgen Inc. | 3 | $94 |
Products named: SKYRIZI, DUPIXENT, SOFDRA, NEMLUVIO, Zoryve, Bimzelx, ANZUPGO, COSENTYX.
Industry payments across MA — which companies pay providers there.
